News
News
- Novan Bolsters Commercialization Expertise with Election of Steven D. Skolsky to Board of Directors
03/02/2021 / 14:30 - GlobeNewswire - Novan Reports Full Year 2020 Financial Results and Provides Corporate Update
02/25/2021 / 13:30 - GlobeNewswire - Novan Completes Enrollment in B-SIMPLE4 Pivotal Phase 3 Study of SB206 for Treatment of Molluscum
02/01/2021 / 14:05 - GlobeNewswire - Novan Regains Compliance with Nasdaq Minimum Bid Price Requirement
01/29/2021 / 22:05 - GlobeNewswire - Novan Provides Enrollment Update and Announces New Corporate Headquarters
01/19/2021 / 15:00 - GlobeNewswire - Novan to Present at the H.C. Wainwright BioConnect 2021 Virtual Conference
01/08/2021 / 15:00 - GlobeNewswire - Novan Engages Catalent to Develop Intranasal Formulation of Berdazimer Sodium for COVID-19 Program
12/21/2020 / 15:00 - GlobeNewswire - Novan Exceeds 60% Enrollment in B-SIMPLE4 Pivotal Phase 3 Study of SB206 for Treatment of Molluscum
12/15/2020 / 15:00 - GlobeNewswire - Novan Receives Approval to Transfer to Nasdaq Capital Market
11/04/2020 / 13:30 - GlobeNewswire - Novan Reports Third Quarter 2020 Financial Results and Provides Corporate Update
10/30/2020 / 12:30 - GlobeNewswire
Real-time